Deleted Tweets From Scott Gottlieb, R-D.C.

RT @FDAOncology: #FDAOncology perspective: Flexibility & innovation in approval strategies for #hematology drugs https://t.co/jzTkhqPKd8

The FDA is aware of reports of a cluster of E. coli O157:H7 cases in New Jersey and the agency stands ready to assist in the investigation. E. coli O157:H7 can cause serious illness. For more information on E. Coli https://t.co/Pq7mFhKJcC

RT @FDAfood: Dr. Gottlieb blogs about #FSMA & what is being done to reduce the risk of intentional adulteration in our food supp… https://t.co/iL1599rRXH

RT @MPEriksen: Washington Post editorial board supporting @FDATobacco plan to reduce #nicotine in combustible products AND support… https://t.co/gqoPXiRYhg

#FDA is taking new steps to work collaboratively with Internet firms and social media companies to crack down on web sales of opioids. We appreciate the voluntary efforts of Internet firms, and we'll soon host a summit to help lead more collective action

Comment periods are open on a series of notices of proposed #FDA regulations seeking to reduce the addictive effects of combustible cigarettes and flavors in cigarettes that lead to youth initiation. We encourage the public to comment on these policies ht

RT @califf001: Critical for those who want to prevent premature death, cancer, heart disease, renal failure, chronic lung disease, etc. to… QT @SGottliebFDA: Comment periods are open on a series of notices of proposed #FDA regulations seeking to reduce the addictive effect… https://t.co/L4A1sU7Ose)

RT @sjtribble: Catch @annaedney and I talking opioids, drug prices and more on Newsmakers today with Scott Gottlieb @CSPAN https://t.co/p9oNfQ56rv

RT @cspan: WATCH: #Newsmakers with FDA Commissioner Dr. Scott Gottlieb (@SGottliebFDA), questions from @annaedney & @sjtribble… https://t.co/OqVh42rIRc

RT @WHO: Before the introduction of #measles vaccine in 1963 and widespread vaccination, an estimated 2.6 million people die… https://t.co/5AfwhV9mIq

Thanks to @cspan for hosting #FDA on NewsMakers show to discuss the Agency's policies on smoking cessation, increasing drug competition to lower costs, and leveraging diet and nutrition as tools to reduce the burden of chronic disease and health inequalit

#FDA looks forward to working with social media sites, ISPs and other Internet firms to cut down on sales of opioids online. FDA will be inviting Internet leaders to a summit on this matter to advance additional, collective efforts by stakeholders https:

RT @FDAOncology: #PatientReportedOutcome measures to inform tolerability- PRO experts, international regulators, @theNCI & patients… https://t.co/63vrsaHqfU

RT @CraigCaplan: Commissioner @SGottliebFDA on FDA's impact on drug pricing on @cspan Newsmakers today https://t.co/y7AI29b5tr https://t.co… QT @annaedney: Dr. Gottlieb: "What people are waiting for is ... the one stroke of a pen that's going to have some big, dramatic i… https://t.co/AdJRomZsg6)

RT @SGottliebFDA: #FDA is taking new steps to work collaboratively with Internet firms and social media companies to crack down on we… https://t.co/CIM6i4CvMD

After careful evaluation, #FDA has also allowed six different manufacturing sites to continue to temporarily import saline, which is helping to meet patient needs until the shortage completely resolves and approved manufacturers can meet all of the U.S. d

The supply situation continues to improve and #FDA continues to monitor it closely. We’re also providing updates through our website, which includes the most current status and product availability as reported to us by the drug manufacturers.

Saline shortage update from #FDA: The firms in Puerto Rico that produce saline have been back online for months and are all producing IV saline; along with two additional firms that received expedited review from the FDA and have also recently begun produ

Use of #PRO measures to inform tolerability in oncology trials: Implications for clinical review, IND safety reporting and clinical site inspections #FDAOncology https://t.co/KOGBgaXJF9

Because of a time lag between production of a saline bag and its eventual arrival at the point of care, significant supply that came on in the last few months is just now having an impact on overall market supply. Any spot shortages should continue to dim

RT @FDAOncology: #FDAOncology perspective: Flexibility & innovation in approval strategies for #hematology drugs https://t.co/jzTkhqPKd8

The FDA is aware of reports of a cluster of E. coli O157:H7 cases in New Jersey and the agency stands ready to assist in the investigation. E. coli O157:H7 can cause serious illness. For more information on E. Coli https://t.co/Pq7mFhKJcC

RT @FDAfood: Dr. Gottlieb blogs about #FSMA & what is being done to reduce the risk of intentional adulteration in our food supp… https://t.co/iL1599rRXH

RT @MPEriksen: Washington Post editorial board supporting @FDATobacco plan to reduce #nicotine in combustible products AND support… https://t.co/gqoPXiRYhg

#FDA is taking new steps to work collaboratively with Internet firms and social media companies to crack down on web sales of opioids. We appreciate the voluntary efforts of Internet firms, and we'll soon host a summit to help lead more collective action

Comment periods are open on a series of notices of proposed #FDA regulations seeking to reduce the addictive effects of combustible cigarettes and flavors in cigarettes that lead to youth initiation. We encourage the public to comment on these policies ht

RT @califf001: Critical for those who want to prevent premature death, cancer, heart disease, renal failure, chronic lung disease, etc. to… QT @SGottliebFDA: Comment periods are open on a series of notices of proposed #FDA regulations seeking to reduce the addictive effect… https://t.co/L4A1sU7Ose)

RT @sjtribble: Catch @annaedney and I talking opioids, drug prices and more on Newsmakers today with Scott Gottlieb @CSPAN https://t.co/p9oNfQ56rv

RT @cspan: WATCH: #Newsmakers with FDA Commissioner Dr. Scott Gottlieb (@SGottliebFDA), questions from @annaedney & @sjtribble… https://t.co/OqVh42rIRc

RT @WHO: Before the introduction of #measles vaccine in 1963 and widespread vaccination, an estimated 2.6 million people die… https://t.co/5AfwhV9mIq

Thanks to @cspan for hosting #FDA on NewsMakers show to discuss the Agency's policies on smoking cessation, increasing drug competition to lower costs, and leveraging diet and nutrition as tools to reduce the burden of chronic disease and health inequalit

#FDA looks forward to working with social media sites, ISPs and other Internet firms to cut down on sales of opioids online. FDA will be inviting Internet leaders to a summit on this matter to advance additional, collective efforts by stakeholders https:

RT @FDAOncology: #PatientReportedOutcome measures to inform tolerability- PRO experts, international regulators, @theNCI & patients… https://t.co/63vrsaHqfU

RT @CraigCaplan: Commissioner @SGottliebFDA on FDA's impact on drug pricing on @cspan Newsmakers today https://t.co/y7AI29b5tr https://t.co… QT @annaedney: Dr. Gottlieb: "What people are waiting for is ... the one stroke of a pen that's going to have some big, dramatic i… https://t.co/AdJRomZsg6)

RT @SGottliebFDA: #FDA is taking new steps to work collaboratively with Internet firms and social media companies to crack down on we… https://t.co/CIM6i4CvMD

After careful evaluation, #FDA has also allowed six different manufacturing sites to continue to temporarily import saline, which is helping to meet patient needs until the shortage completely resolves and approved manufacturers can meet all of the U.S. d

The supply situation continues to improve and #FDA continues to monitor it closely. We’re also providing updates through our website, which includes the most current status and product availability as reported to us by the drug manufacturers.

Saline shortage update from #FDA: The firms in Puerto Rico that produce saline have been back online for months and are all producing IV saline; along with two additional firms that received expedited review from the FDA and have also recently begun produ

Use of #PRO measures to inform tolerability in oncology trials: Implications for clinical review, IND safety reporting and clinical site inspections #FDAOncology https://t.co/KOGBgaXJF9

Because of a time lag between production of a saline bag and its eventual arrival at the point of care, significant supply that came on in the last few months is just now having an impact on overall market supply. Any spot shortages should continue to dim